Total homocysteine (tHcy) level was identified as a strong and independent predictor of cardiovascular events. We investigated the association between tHcy and mechanical properties of large arteries in a random, general population-based sample of 251 subjects (mean age 48 years). Large artery properties, such as aortic and peripheral (lower-limb) pulse wave velocity (PWV), and augmentation index of radial artery were measured using semi-automatic Sphygmocor s device. Aortic PWV (APWV) positively correlated with tHcy (r ¼ 0.28, Po0.0001), and a significant increasing trend of APWV was found by tHcy quartiles (P ¼ 0.0003 by ANOVA). This association remained significant after adjustment for conventional cardiovascular risk factors (age, gender, smoking, overweight, hypertension, dyslipidaemia and impaired glucose metabolism) and for usual homocysteine confounders (folate, B 12 , renal function). Subjects with mild hyperhomocysteinaemia (i.e. with tHcy X15 lmol/l) had 2.74 times higher risk of having their APWV over 8.42 m/s (i.e. in the top quartile). No such association was found either for PWV measured at lower extremity or for radial augmentation index. In conclusion, in our series of subjects from general population, we found a strong and independent relationship between homocysteine concentration and APWV, a parameter of stiffness of central arteries.
Introduction
Numerous prospective studies identified homocysteine as a strong predictor of vascular diseases. Patients with plasma total homocysteine (tHcy) of 15-19.9 mmol/l had about 2.5 times higher mortality and those with tHcy more than 20 mmol/l about six times higher mortality than patients with tHcyo 9 mmol/l. 1 There are several potential vascular consequences of elevated tHcy. Besides well-evident effect on coagulation, oxidative status and endothelial dysfunction, 2 several experimental studies reported that elevated tHcy can induce smooth muscle proliferation, collagen synthesis and deterioration of the elastic structures of the vessel wall, [3] [4] [5] [6] a phenomenon resulting in increased stiffness of vessel wall.
Recent studies identified increased large artery stiffness as independent predictor of cardiovascular outcomes. Laurent et al. 7 reported that a 5 m/s increase of carotid-femoral pulse-wave velocity (a marker of aortic stiffness) was associated in hypertensive patients with 2.35 times higher risk of cardiovascular death. Similar relationship between aortic stiffness and mortality were found in subjects older than 70 years 8 and in patients with end-stage renal disease. 9 The aim of our study was to establish whether or not there exists an association between homocysteine concentrations and arterial stiffness; we further asked whether this association is independent of other cardiovascular risk factors and parameters known to influence the homocysteine concentrations.
Methods

Subjects
The study population consisted from random general population sample. A survey of risk factors was undertaken in 2000-2001 as a part of Czech post-MONICA study. 10 One per cent of residents of City of Pilsen, aged 25-65 years, was selected (stratified by age and sex) from the General Health Insurance Registry. A total of 1009 subjects, 488 males and 522 females, mean age 48.1, responded to the survey.
A random 25% subsample, in which arterial properties were examined, was evaluated in the present study.
Examinations and materials
All study procedures were done according to Good Clinical Practice regulation and were approved by the Local Ethical Committee. The Informed consent was obtained from all subjects and all personal data were stored under the provisions of the Czech Data Protection Act. All responders were interviewed and examined by standardized methods using WHO Monica standard manual. Methods of interview were described in details elsewhere. 10 Briefly, information on personal and demographic characteristics, personal and family history of coronary heart disease, lifestyle and current pharmacotherapy were obtained at interview. Following standardized examinations were performed: height and weight in light indoor clothes without shoes by DETECTO 20 (Webb City, USA) scale and measuring stick. Blood pressure (BP) was measured three times in the sitting position on the right arm using standard mercury sphygmomanometers to the nearest 2 mmHg; appropriate cuff size was used.
Large artery properties were measured using the semi-automatic Sphygmocor device (AtCor Medical Ltd, Australia); the methods of measurement were described in detail in our previous report. 11 The first part of this examination was the registration of radial pulse wave which was used to evaluate wave reflection; the parameter showing wave reflection is augmentation index (AIx), defined as the ratio of pulse pressure at the peaks of secondary to primary wave. Immediately before the radial pulse wave registration, an additional BP reading was obtained using the Omron 705CP oscillometric device. The probability of observer bias is minimized with this type of device. The second part of the examination was pulse wave velocity (PWV) measurement assessing arterial stiffness. We used the same device and measured it with the patient in supine position in the aorta, that is, between carotid and femoral arteries (aortic PWV, APWV), and in the lower extremity, that is, between femoral and dorsalis pedis/tibialis posterior arteries (peripheral PWV, PWV). Consecutive registrations of the pulse waves are ECG gated and thus, the time shift between the appearance of wave at the first and the second sites can be calculated. The distance between the two sites was measured on the body surface; to determine APWV, we measured the distance from the jugular fossa to the pulsation of the femoral artery in the groin subtracting, from this distance, the distance from the jugular fossa to carotid pulsation as the pulse runs here in the direction opposite to that in the aorta. The average of measurements over a period of 8 s (nine to ten cardiac cycles) was calculated after the exclusion of extreme values.
The methods were shown to have good reproducibility. 12, 13 Venous blood samples were drawn in fasting state, and frozen serum samples, stored at À801C, were used for biochemical laboratory analyses in the series. The laboratory examinations, including assessment of total (TCHOL) and HDL cholesterol (HDL), triglycerides (TG) were provided by the central laboratories of survey (Institute of Clinical and Experimental Medicine, Prague) using Cobas Mira analyser (Basel, Switzerland) and commercially available kits of the same provenience. Glucose levels (GLU) were analysed by enzymatic method in the same laboratory using LACHEMA (Brno, Czech Republic) standard kits. LDL cholesterol (LDL) was calculated by Friedewald Equation that is, LDL ¼TCHOLÀHDLÀ(TG/5). Serum tHcy, plasma folate and B 12 vitamin (B 12 ) concentrations were estimated from aliquots series, stored at À801C, by commercial FPIA kits and automatic analysers (AxSYM, Abbott Laboratories, Wiesbaden, Germany, for tHcy, and ACCESS Beckman Coulter, Fullerton, USA, for folate and B 12 ). Variation for all these measurements was less than 1.5%.
Data analysis
The study was designed as a cross-sectional analysis. Statistical analysis of the data was done using STATA 6. Power calculation was done using standard deviations, ascertained in our previous studies. The minimal sample size, necessary to detect the differences in measured variables at 5% significance and 90% power, was 107 subjects. The significance of differences among specific groups was evaluated by Fishers w 2 -test for categorical variables and by analysis of variance (ANOVA) or Mann-Whitney U test for continuous variables. Multiple logistic regression was used to ascertain the association between tHcy and large artery properties after adjustment for potential confounders.
Results
A total of 251 subjects, aged 48.170.69 years (mean7s.e.m.), 126 males and 125 females, were evaluated in the present study. Baseline characteristics of study sample as a whole and variables sorted by tHcy quartiles are given in Table 1 . Statistically significant increasing trends were found in age, systolic blood pressure, use of lipidlowering drugs and APWV across tHcy quartiles, while there were decreasing trends in folate and B 12 vitamin concentrations. Similar statistical differences were found, when only lowest and highest quartile were compared; moreover, there was a higher BMI and lower proportion of females in the highest quartile.
The relation between APWV and tHcy in a continuous manner is shown in Figure 1 . A statistically significant positive association was found between these two variables, Spearman's correlation coefficient was 0.28 (with P-value 0.000005).
Associations between APWV and categorized cardiovascular risk factors are given in Table 2 . Subjects with mild hyperhomocysteinaemia (i.e. with tHcy X15 mmol/l) had 2.74 times higher risk of having their APWV over 8.42 m/s. Out of other cardiovascular risk factors, age X50 years, hypertension and overweight significantly and independently entered the regression (model A). The association between increased APWV and homocysteinaemia remained significant after adjustment for factors known to influence the tHcy levels such as age, gender, current smoking, folate, B 12 concentrations and treatment with fibrates (Table 2 , model B). No significant relation was found between tHcy concentrations and PPWV or radial AIx.
Discussion
We found in our study that elevated homocysteine was significantly associated with increased central arterial stiffness, measured by APWV. Relative risk of increased APWV (over 8.42 m/s, i.e., in the top quartile) was nearly three times higher for subjects with homocysteine X15 mmol/l (i.e. with mild hyperhomocysteinaemia according to usual definition); this association remained significant after adjustment for other cardiovascular risk factors or parameters, known to influence the homocysteine concentrations. These findings are in agreement with some already published data. Bortolotto et al. 14 reported that homocysteine strongly and independently correlate with APWV in patients with hypertension. Sutton-Tyrrel et al. 15 reported an independent relation between elevated homocysteine and isolated systolic hypertension, a clinical manifestation of increased aortic stiffness, in older adults. Figure 1 Correlation between total homocysteine concentration and aortic pulse wave velocity (Spearman's correlation coefficient).
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It is evident, that aortic stiffness is strongly related mainly to age, because of age-dependent changes in elastin and collagen content in the vessel wall. However, homocysteine may probably accelerate this process. It was reported, that homocysteine gradually increased collagen synthesis in vascular smooth muscle cells culture (VSMC) and was accompanied by an excessive accumulation of insoluble collagen in the cell layer, indicating the impaired collagen degradation. 4, 5 Charpiot et al. 6 reported, that dietary-induced hyperhomocysteinaemia in minipig decreased, subsequently, the elastin content and increased metalloproteinase-dependent elastolysis in abdominal aorta and coronary arteries. The link between collagen/elastin metabolism and homocysteine could be a hypothetical explanation of differential effect on central and peripheral artery stiffness. Central arteries (such as aorta) contain relatively more elastin and less collagen than peripheral arteries. Thus, aorta could be more dependent than the peripheral arteries on any imbalance in elastin and collagen synthesis/degradation, namely in subjects free of manifest vascular disease. Two studies reported that aortic stiffness could also be increased by acute rise in homocysteine concentration. Nestel et al. 16 found that oral methionine load, causing a threefold increase in tHcy concentration, caused increase of stiffness in the central arterial system by about 22%; the stiffness was measured at baseline and 5 h after the methionine load. Similarly, Davis et al. 17 reported that acute tHcy elevation significantly increased pulse pressure (as a marker of central arterial stiffness) by about 4 mmHg, measured 8 h after methionine load. There is a hypothetical explanation of this acute effect of homocysteine from experimental studies. Neves et al. 18 found in an experimental study that treatment with angiotensin-II increased arterial stiffness of mesenteric artery significantly more in hyperhomocysteinaemic (methylenetetrahydrofolate reductase deficient), than in control normohomocysteinaemic (wild-type) mice. Another experimental study 19 found in rats that elevated homocysteine increased extremely the responsiveness of its aortic vascular smooth muscle cells to angiontensin-II. Thus, homocysteine may probably induce vascular reactivity in conjunction with other vasoactive agents, such as angiotensin-II.
Various methods can be used for the evaluation of arterial wall properties. In some studies, Doppler ultasound technique is used for the measurement of PWV: it is obtained by dividing the length of a particular arterial segment by the 'foot-to-foot' transit time. It has been shown that APWV measured with this method predicts strongly and independently cardiovascular mortality in patients with end-stage renal disease. 20 Magnetic resonance imaging is a method enabling to study biophysical properties of aortic segments in details (distensibility, pulse and flow wave velocities). This method has been used for the studies in special diseases where arterial function is likely to be altered, such as juvenile arthritis 21 or Marfan syndrome. 22 For the purpose of a population-based study, however, our sphygmometric method is the most suitable as it is relatively simple, fast, well reproducible and inexpensive. A large arterial segment, such as the aorta or lower extremity arteries, is studied as a whole and therefore, the result of a measurement is not much influenced, for example, by the presence of a local atherosclerotic lesion.
In conclusion, in our study we found a strong and independent relationship between total serum homocysteine concentrations and APWV, as a parameter of central arterial stiffness. On the other hand, owing to cross-sectional design of our study, we have no direct evidence for cause-effect interaction. The causality of elevated homocysteine in increased aortic stiffness needs to be confirmed by interventional prospective study with folate, which represents a standard treatment approach in mild hyperhomocysteinaemia.
